)
4DMedical (4DX) investor relations material
4DMedical Investor Update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Business and Product Update
CT:VQ, a non-invasive lung imaging software, is FDA-cleared and uniquely visualizes blood flow without contrast injections, streamlining workflow and improving patient experience.
The addressable U.S. market is estimated at $1.15 billion, focused on one million annual VQ scans, with global opportunities and expansion into related imaging markets.
CT:VQ offers significant operational and economic advantages, reducing procedure time and infrastructure needs, and enabling higher revenue per minute for hospitals.
The technology can be applied retrospectively to archived CT scans, allowing additional reimbursable analyses and supporting longitudinal patient care.
CT:VQ delivers quantitative ventilation-perfusion data from routine non-contrast CT scans, eliminating the need for radiotracers and integrating with existing CT protocols.
Strategic Partnership and Commercial Agreement
Philips will distribute CT:VQ across North America with a minimum order commitment of US$10m over two years, providing revenue visibility through milestone-based financial commitments.
Dedicated Philips sales and clinical teams will target US and Canadian healthcare systems, with joint marketing and co-branding initiatives launching at RSNA 2025.
The Philips partnership includes exclusivity for U.S. government sales, notably the VA, and leverages their extensive U.S. hospital network and PACS install base.
Broad accessibility leverages 14,500 CT scanners in the US, extending advanced imaging to rural and community facilities.
Market Traction and Competitive Positioning
Strong interest and demand from leading U.S. hospitals and radiologists, with a strategy to secure top-tier academic medical centers as reference customers.
Over 100 patents and a large, experienced R&D team provide a robust competitive moat, with ongoing innovation and regulatory advantages over AI-based competitors.
The company is well-funded, with cash reserves and additional capital expected from exercised options.
Reimbursement rates are favorable, with Medicare and private insurers, and the product's workflow benefits are a key driver for hospital adoption.
Next 4DMedical earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)